新西兰不同人群烟雾血管病的种族差异:一项基于人群的队列研究。

IF 4 3区 医学 Q2 CLINICAL NEUROLOGY
Karim M Mahawish
{"title":"新西兰不同人群烟雾血管病的种族差异:一项基于人群的队列研究。","authors":"Karim M Mahawish","doi":"10.1159/000548482","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Moyamoya angiopathy (MMA) has been reported in the ethnically diverse Auckland region of New Zealand, but the sociodemographic burden and clinical outcomes remain poorly characterised. This study aims to determine age, sex, and prevalence of MMA stratified by ethnicity, and to assess clinical outcomes in adults residing in Auckland (population 1.9 million).</p><p><strong>Methods: </strong>A retrospective review of patient records and radiology reports from 2008 to 2025 was conducted using ICD codes and keyword searches. Prevalence was estimated using national census data. Primary outcomes were functional independence (modified Rankin Score 0-2) and the composite of stroke or transient ischaemic attack (TIA). Associations were assessed using univariate and multivariate Cox regression. A pooled analysis of published cohorts was also performed for context.</p><p><strong>Results: </strong>A total of 100 patients were identified (73% female; mean age 38.5 years, SD 17). Period prevalence was highest among Pacific peoples (11/100,000), followed by Māori (6/100,000), Asians (4/100,000), and Europeans (2/100,000). Overall prevalence increased from 0.8 to 4.5 per 100,000 between 2001 and 2025 (p<0.0001). During a median follow-up of 4.2 years, 39% experienced a cerebrovascular event, at a median of 647 days from diagnosis. Two-thirds remained functionally independent. Bilateral internal carotid artery involvement (HR 0.52, 95% CI 0.30-0.91) and recurrent cerebrovascular events (HR 0.54, 95% CI 0.31-0.94) were associated with poorer outcomes, while antithrombotic use was protective (HR 2.1, 95% CI 1.11-3.9). Outcomes were consistent with other international cohorts.</p><p><strong>Conclusion: </strong>This population-based study highlights marked ethnic variation in MMA prevalence, with the highest rates in Pacific peoples, and an elevated risk of early cerebrovascular events. These findings have implications for timely diagnosis and targeted management in diverse populations.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-20"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study.\",\"authors\":\"Karim M Mahawish\",\"doi\":\"10.1159/000548482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Moyamoya angiopathy (MMA) has been reported in the ethnically diverse Auckland region of New Zealand, but the sociodemographic burden and clinical outcomes remain poorly characterised. This study aims to determine age, sex, and prevalence of MMA stratified by ethnicity, and to assess clinical outcomes in adults residing in Auckland (population 1.9 million).</p><p><strong>Methods: </strong>A retrospective review of patient records and radiology reports from 2008 to 2025 was conducted using ICD codes and keyword searches. Prevalence was estimated using national census data. Primary outcomes were functional independence (modified Rankin Score 0-2) and the composite of stroke or transient ischaemic attack (TIA). Associations were assessed using univariate and multivariate Cox regression. A pooled analysis of published cohorts was also performed for context.</p><p><strong>Results: </strong>A total of 100 patients were identified (73% female; mean age 38.5 years, SD 17). Period prevalence was highest among Pacific peoples (11/100,000), followed by Māori (6/100,000), Asians (4/100,000), and Europeans (2/100,000). Overall prevalence increased from 0.8 to 4.5 per 100,000 between 2001 and 2025 (p<0.0001). During a median follow-up of 4.2 years, 39% experienced a cerebrovascular event, at a median of 647 days from diagnosis. Two-thirds remained functionally independent. Bilateral internal carotid artery involvement (HR 0.52, 95% CI 0.30-0.91) and recurrent cerebrovascular events (HR 0.54, 95% CI 0.31-0.94) were associated with poorer outcomes, while antithrombotic use was protective (HR 2.1, 95% CI 1.11-3.9). Outcomes were consistent with other international cohorts.</p><p><strong>Conclusion: </strong>This population-based study highlights marked ethnic variation in MMA prevalence, with the highest rates in Pacific peoples, and an elevated risk of early cerebrovascular events. These findings have implications for timely diagnosis and targeted management in diverse populations.</p>\",\"PeriodicalId\":54730,\"journal\":{\"name\":\"Neuroepidemiology\",\"volume\":\" \",\"pages\":\"1-20\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroepidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000548482\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroepidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548482","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:烟雾血管病(MMA)已经在新西兰奥克兰地区的种族多样化的报道,但社会人口负担和临床结果仍然缺乏特征。本研究旨在确定年龄、性别和按种族分层的MMA患病率,并评估居住在奥克兰(人口190万)的成年人的临床结果。方法:采用ICD编码和关键词检索对2008年至2025年的患者病历和放射学报告进行回顾性分析。使用全国人口普查数据估计患病率。主要结局是功能独立性(修正Rankin评分0-2)和卒中或短暂性脑缺血发作(TIA)的综合。使用单因素和多因素Cox回归评估相关性。还对已发表的队列进行了汇总分析。结果:共发现100例患者(73%为女性,平均年龄38.5岁,SD 17)。期间患病率最高的是太平洋人(11/100,000),其次是Māori(6/100,000)、亚洲人(4/100,000)和欧洲人(2/100,000)。从2001年到2025年,MMA的总患病率从0.8 / 10万上升到4.5 / 10万。结论:这项基于人群的研究突出了MMA患病率的显著种族差异,太平洋地区的发病率最高,早期脑血管事件的风险也较高。这些发现对不同人群的及时诊断和有针对性的管理具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study.

Introduction: Moyamoya angiopathy (MMA) has been reported in the ethnically diverse Auckland region of New Zealand, but the sociodemographic burden and clinical outcomes remain poorly characterised. This study aims to determine age, sex, and prevalence of MMA stratified by ethnicity, and to assess clinical outcomes in adults residing in Auckland (population 1.9 million).

Methods: A retrospective review of patient records and radiology reports from 2008 to 2025 was conducted using ICD codes and keyword searches. Prevalence was estimated using national census data. Primary outcomes were functional independence (modified Rankin Score 0-2) and the composite of stroke or transient ischaemic attack (TIA). Associations were assessed using univariate and multivariate Cox regression. A pooled analysis of published cohorts was also performed for context.

Results: A total of 100 patients were identified (73% female; mean age 38.5 years, SD 17). Period prevalence was highest among Pacific peoples (11/100,000), followed by Māori (6/100,000), Asians (4/100,000), and Europeans (2/100,000). Overall prevalence increased from 0.8 to 4.5 per 100,000 between 2001 and 2025 (p<0.0001). During a median follow-up of 4.2 years, 39% experienced a cerebrovascular event, at a median of 647 days from diagnosis. Two-thirds remained functionally independent. Bilateral internal carotid artery involvement (HR 0.52, 95% CI 0.30-0.91) and recurrent cerebrovascular events (HR 0.54, 95% CI 0.31-0.94) were associated with poorer outcomes, while antithrombotic use was protective (HR 2.1, 95% CI 1.11-3.9). Outcomes were consistent with other international cohorts.

Conclusion: This population-based study highlights marked ethnic variation in MMA prevalence, with the highest rates in Pacific peoples, and an elevated risk of early cerebrovascular events. These findings have implications for timely diagnosis and targeted management in diverse populations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neuroepidemiology
Neuroepidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
9.90
自引率
1.80%
发文量
49
审稿时长
6-12 weeks
期刊介绍: ''Neuroepidemiology'' is the only internationally recognised peer-reviewed periodical devoted to descriptive, analytical and experimental studies in the epidemiology of neurologic disease. The scope of the journal expands the boundaries of traditional clinical neurology by providing new insights regarding the etiology, determinants, distribution, management and prevention of diseases of the nervous system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信